AOP 03-007 - ANAHYDRET Study A single blind, multi-centre, randomised multinational Phase III Study to compare the Efficacy and Tolerability of Anagrelide vs Hydroxyurea in Patients with Essential Thrombocythaemia
Main Overview Study Protocol Appendix I Activity Sheet Contact
	The study has been closed as the recruitment goal of 258 patients has been reached. For details see here.